Management of Rectal Cancer
- PMID: 32402304
- DOI: 10.1016/j.suc.2020.02.014
Management of Rectal Cancer
Abstract
Rectal cancer is often presented with a dizzying array of treatment recommendations. This article clarifies and simplifies this common clinical problem from the surgical perspective. Treatment of rectal cancer requires an understanding of presenting stage (early or advanced) and location (high or low) to provide oncologic sound treatment decisions. Surgical treatment requires a minimum of 1 cm distal margin, careful clearance of the mesorectum and radial margin using total mesorectal excision technique, and 12 or more regional lymph nodes harvested and analyzed. Appropriate and effective multimodality treatments exist and must be used based on sound guidelines as outlined.
Keywords: Multimodality treatment; Rectal cancer; Staging; Surgical techniques.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The author has nothing to disclose.
Similar articles
-
Distal intramural and tumor spread in the mesorectum after neoadjuvant radiochemotherapy in rectal cancer: about 124 consecutive patients.Hum Pathol. 2016 Jun;52:164-72. doi: 10.1016/j.humpath.2016.01.017. Epub 2016 Feb 10. Hum Pathol. 2016. PMID: 27210028
-
Cancer of the upper rectum.Dan Med J. 2016 Oct;63(10):B5227. Dan Med J. 2016. PMID: 27697137 Review.
-
Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.PLoS One. 2015 Sep 18;10(9):e0138728. doi: 10.1371/journal.pone.0138728. eCollection 2015. PLoS One. 2015. PMID: 26381522 Free PMC article.
-
Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.Colorectal Dis. 2016 Sep;18(9):O314-21. doi: 10.1111/codi.13449. Colorectal Dis. 2016. PMID: 27381492
-
Rectal cancer surgery and regional lymph nodes.J Surg Oncol. 2009 Mar 15;99(4):256-9. doi: 10.1002/jso.21217. J Surg Oncol. 2009. PMID: 19101955 Review.
Cited by
-
Diagnostic yield and repeat biopsies in rectal and nonrectal colorectal adenocarcinoma: Are we hedging on rectal biopsies?Acad Pathol. 2023 Feb 1;10(1):100063. doi: 10.1016/j.acpath.2022.100063. eCollection 2023 Jan-Mar. Acad Pathol. 2023. PMID: 36970329 Free PMC article.
-
Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy.Cancers (Basel). 2023 Mar 17;15(6):1828. doi: 10.3390/cancers15061828. Cancers (Basel). 2023. PMID: 36980714 Free PMC article.
-
Efficacy and safety of intraoperative radiotherapy in rectal cancer: A systematic review and meta-analysis.World J Gastrointest Oncol. 2021 Jan 15;13(1):69-86. doi: 10.4251/wjgo.v13.i1.69. World J Gastrointest Oncol. 2021. PMID: 33510850 Free PMC article.
-
The Role of Frailty in the Treatment of Locally Advanced Rectal Cancer.Cancers (Basel). 2024 Sep 27;16(19):3287. doi: 10.3390/cancers16193287. Cancers (Basel). 2024. PMID: 39409908 Free PMC article. Review.
-
Tuning vision foundation models for rectal cancer segmentation from CT scans.Commun Med (Lond). 2025 Jul 1;5(1):256. doi: 10.1038/s43856-025-00953-0. Commun Med (Lond). 2025. PMID: 40595386 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources